DCM
ASPX

Driehaus Capital Management’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Driehaus Capital Management’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-69,085
Closed -$6.93M – 657
2015
Q1 		$6.93M Buy
69,085
+407
+0.6% +$27.1K 0.24% 105
2014
Q4 		$3.6M Buy
68,678
+1,938
+3% +$56.9K 0.15% 195
2014
Q3 		$1.71M Sell
66,740
-49,288
-42% -$1.05M 0.07% 356
2014
Q2 		$2.58M Buy
116,028
+13,476
+13% +$295K 0.08% 302
2014
Q1 		$3.15M Buy
+102,552
New +$2.76M 0.1% 253

Driehaus Capital Management's ASPX Position: Q2 2015 in Review

Driehaus Capital Management sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 69,085 shares — an estimated $6.93M sold.

Driehaus Capital Management first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $6.93M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Driehaus Capital Management reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Driehaus Capital Management sold 69,085 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $6.93M.
  • Driehaus Capital Management first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • Driehaus Capital Management's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $6.93M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Driehaus Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.